Rhenman & Partners Asset Management AB boosted its holdings in shares of Encompass Health Corporation (NYSE:EHC – Free Report) by 22.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 146,263 shares of the company’s stock after purchasing an additional 26,863 shares during the period. Encompass Health accounts for approximately 1.5% of Rhenman & Partners Asset Management AB’s holdings, making the stock its 28th largest holding. Rhenman & Partners Asset Management AB’s holdings in Encompass Health were worth $15,524,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Northwestern Mutual Wealth Management Co. boosted its position in Encompass Health by 3,059,159.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock valued at $402,640,000 after buying an additional 3,793,358 shares during the last quarter. Alliancebernstein L.P. increased its stake in shares of Encompass Health by 23.4% in the 3rd quarter. Alliancebernstein L.P. now owns 2,515,878 shares of the company’s stock valued at $319,567,000 after buying an additional 476,564 shares during the period. Geode Capital Management LLC increased its stake in shares of Encompass Health by 7.6% in the 4th quarter. Geode Capital Management LLC now owns 1,946,134 shares of the company’s stock valued at $206,605,000 after buying an additional 137,892 shares during the period. Dimensional Fund Advisors LP increased its stake in shares of Encompass Health by 0.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,624,137 shares of the company’s stock valued at $172,396,000 after buying an additional 7,959 shares during the period. Finally, Raymond James Financial Inc. increased its stake in shares of Encompass Health by 34.8% in the 3rd quarter. Raymond James Financial Inc. now owns 1,541,336 shares of the company’s stock valued at $195,780,000 after buying an additional 397,694 shares during the period. 97.25% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several equities research analysts have recently commented on EHC shares. Barclays lowered their target price on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, May 5th. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Weiss Ratings reissued a “buy (b-)” rating on shares of Encompass Health in a research note on Monday. TD Cowen started coverage on Encompass Health in a research note on Thursday, May 28th. They issued a “buy” rating and a $125.00 target price for the company. Finally, Leerink Partners set a $152.00 target price on Encompass Health in a research note on Friday, May 22nd. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $143.86.
Insider Activity
In other news, EVP Patrick William Tuer sold 682 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the transaction, the executive vice president directly owned 24,755 shares in the company, valued at $2,588,382.80. This trade represents a 2.68% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.80% of the stock is owned by corporate insiders.
Encompass Health Stock Down 0.9%
NYSE:EHC opened at $101.49 on Friday. Encompass Health Corporation has a 12-month low of $92.77 and a 12-month high of $127.99. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.76. The firm has a market capitalization of $10.07 billion, a P/E ratio of 16.94, a P/E/G ratio of 2.23 and a beta of 0.72. The stock’s fifty day simple moving average is $104.31 and its 200-day simple moving average is $104.65.
Encompass Health (NYSE:EHC – Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The business had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.57 billion. During the same period last year, the company earned $1.37 EPS. The firm’s revenue was up 9.0% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Equities research analysts expect that Encompass Health Corporation will post 5.97 earnings per share for the current year.
Encompass Health Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be given a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, July 1st. Encompass Health’s dividend payout ratio (DPR) is currently 12.69%.
Encompass Health Company Profile
Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.
Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.
Featured Articles
- Five stocks we like better than Encompass Health
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC – Free Report).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
